Form 4 Tracker
BridgeBio Pharma, Inc.
BBIO

45 insider filings · Latest: Sep 17, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Sep 17, 2026Sep 21 10:21 PMNeil KumarDirector, Chief Executive Officer
Sale
10,000$69.08$690.8K495,686(I)

View →

Aug 19, 2026Aug 20 8:31 PMNeil KumarDirector, Chief Executive Officer
Sale
10,000$84.03$840.3K505,686(I)

View →

Aug 18, 2026Aug 20 8:31 PMNeil KumarDirector, Chief Executive Officer
Sale
34,980$82.53$2.9M243,327(D)

View →

Aug 19, 2026Aug 19 8:34 PMKUMAR HALDEA FAMILY IRREVOCABLE TRU/T/A DTD 05/18/2019
Proposed Sale
30,000$82.98$2.5M—

View →

Aug 18, 2026Aug 18 8:26 PMNEIL KUMAR
Proposed Sale
34,980$79.89$2.8M—

View →

Aug 17, 2026Aug 17 8:32 PMRANDAL SCOTT
Proposed Sale
21,501$79.86$1.7M—

View →

Jul 30, 2026Aug 3 8:20 PMMaricel ApuliChief Accounting Officer
Sale
2,000$80.06$160.1K127,401(D)

View →

Jul 9, 2026Jul 13 8:41 PMAndrea EllisDirector
Sale
17,167$84.00$1.4M22,579(D)

View →

Jul 9, 2026Jul 13 8:40 PMJennifer E. CookDirector
Sale
148,589$88.54$13.2M8,383(D)

View →

Jul 9, 2026Jul 9 8:22 PMJENNIFER COOK
Proposed Sale
148,589$88.54$13.2M—

View →

Jul 9, 2026Jul 9 8:11 PMANDREA ELLIS
Proposed Sale
17,167$84.00$1.4M—

View →

Jun 24, 2026Jun 24 10:06 PMJennifer E. CookDirector
Sale
37,167$70.00$2.6M8,383(D)

View →

Jun 23, 2026Jun 24 10:06 PMJennifer E. CookDirector
Sale
2,196$68.57$150.6K8,383(D)

View →

Jun 23, 2026Jun 24 10:06 PMHannah ValantineDirector
Sale
2,196$68.57$150.6K9,259(D)

View →

Jun 22, 2026Jun 24 10:06 PMHannah ValantineDirector
Sale
2,808$68.00$190.9K11,455(D)

View →

Jun 24, 2026Jun 24 8:34 PMRANDAL SCOTT
Proposed Sale
2,196$68.63$150.7K—

View →

Jun 24, 2026Jun 24 8:08 PMJENNIFER COOK
Proposed Sale
37,167$70.00$2.6M—

View →

Jun 23, 2026Jun 23 8:33 PMJENNIFER COOK
Proposed Sale
2,196$68.57$150.6K—

View →

Jun 23, 2026Jun 23 8:02 PMHANNAH A VALANTINE
Proposed Sale
2,196$68.57$150.6K—

View →

Jun 22, 2026Jun 22 8:06 PMHANNAH A VALANTINE
Proposed Sale
2,808$68.00$190.9K—

View →

Page 1 of 5

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Aug 16, 2026Aug 18 10:02 PMNeil KumarDirector, Chief Executive Officer
Option Exercise
71,217—91,274(D)

View →

Jul 9, 2026Jul 13 8:41 PMAndrea EllisDirector
Option Exercise
17,167$16.7517,167(D)

View →

Jul 9, 2026Jul 13 8:40 PMJennifer E. CookDirector
Option Exercise
148,589$29.000(D)

View →

Jun 24, 2026Jun 24 10:06 PMJennifer E. CookDirector
Option Exercise
37,167$16.7517,167(D)

View →

Jun 22, 2026Jun 24 10:06 PMJennifer E. CookDirector
Grant/Award
5,277$68.925,277(D)

View →

Jun 22, 2026Jun 24 10:06 PMHannah ValantineDirector
Grant/Award
5,277$68.925,277(D)

View →

Jun 22, 2026Jun 24 10:06 PMHannah ValantineDirector
Option Exercise
2,808$41.735,617(D)

View →

Jun 22, 2026Jun 24 10:06 PMLo AndrewDirector
Grant/Award
5,277$68.925,277(D)

View →

Jun 22, 2026Jun 24 10:06 PMCharles J HomcyDirector
Grant/Award
5,277$68.925,277(D)

View →

Jun 22, 2026Jun 24 10:06 PMEric AguiarDirector
Grant/Award
5,277$68.925,277(D)

View →

Jun 22, 2026Jun 24 10:05 PMDANIELS RONALD JDirector
Grant/Award
5,277$68.925,277(D)

View →

Jun 22, 2026Jun 24 10:05 PMAndrea EllisDirector
Grant/Award
5,277$68.925,277(D)

View →

Jun 22, 2026Jun 24 10:05 PMHassan FredDirector
Grant/Award
5,277$68.925,277(D)

View →

Jun 22, 2026Jun 24 10:05 PMJames C MomtazeeDirector
Grant/Award
5,277$68.925,277(D)

View →

Jun 22, 2026Jun 24 10:05 PMFrank MccormickDirector
Grant/Award
5,277$68.925,277(D)

View →

Jun 22, 2026Jun 24 10:05 PMDouglas A. DachilleDirector
Grant/Award
5,277$68.925,277(D)

View →

Jun 22, 2026Jun 24 10:05 PMAli J. SatvatDirector
Grant/Award
5,277$68.925,277(D)

View →

Jun 15, 2026Jun 17 8:45 PMJennifer E. CookDirector
Option Exercise
83,088$16.7534,334(D)

View →

May 16, 2026May 19 8:27 PMNeil KumarDirector, Chief Executive Officer
Option Exercise
71,215—97,794(D)

View →

May 15, 2026May 19 8:25 PMRandal W. ScottDirector
Option Exercise
10,000$16.7521,501(D)

View →

Page 1 of 2

Next →